Evan Sasson is a pharmacist who is specialized in Ambulatory Care in Brooklyn, New York. Patients can reach him at 121 Dekalb Ave, Brooklyn or contact him on 718-250-8000. Active license number of Evan Sasson is 059838 for Ambulatory Care in New York. Evan Sasson is a licensed pharmacist who has demonstrated specialized knowledge and skill in the provision of integrated, accessible health care services by pharmacists and is accountable for addressing medication needs, developing sustained partnerships with patients, and practicing in the context of family and community.
Complete Profile:
Evan Sasson speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Evan Sasson
Specialization:
Ambulatory Care
Gender:
Male
Location:
121 Dekalb Ave, Brooklyn, New York, 11201-5425
Phone:
718-250-8000
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Evan Sasson are as mentioned below.
NPI Number:
1417402595
NPI Enumeration Date:
18 Aug, 2016
NPI Last Update On:
30 Jun, 2020
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Evan Sasson are as mentioned below.
Specialization
License Number
State
Status
Ambulatory Care
059838
New York
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
121 Dekalb Ave, Brooklyn, New York
Zip:
11201-5493
Phone Number:
718-250-8524
Fax Number:
--
Patients can reach Evan Sasson at 121 Dekalb Ave, Brooklyn, New York or can call on phone at 718-250-8000.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.